Results 121 to 130 of about 711,467 (262)
British Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 2070-2079, July 2025.Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Rosa Luo +6 more
wiley +1 more source
Surgical Management of Left-Sided Carcinoid Heart Disease [PDF]
, 2001 Heidi M. Connolly +5 more
openalex +2 more sources
Swollen limbs and bone pain : a case report [PDF]
, 2005 A 50 year old man presented with peripheral oedema, abdominal distension and a pulmonary opacity on CXR. He subsequently perforated his sigmoid colon as a complication of diverticulitis with pericolic abscess. After colectomy his postoperative period was
Cacciottolo, Joseph M. +2 more
core
A patient-reported outcomes analysis of lanreotide in the treatment of NETs patients with carcinoid syndrome : evidence from the ELECT trial [PDF]
, 2019 Purpose: The purpose of this analysis of patient-reported outcomes from the ELECT (Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment) trial (NCT00774930) was to explore the effect of lanreotide on symptoms of ...
Blot, Koenraad +6 more
core +1 more source
Journal of International Medical Research, 2020 Carcinoid heart disease is a late complication of carcinoid syndrome, and imaging can help in the diagnosis of diffuse cardiac metastasis. We herein report a case of diffuse cardiac metastasis of a neuroendocrine tumor of the thymus diagnosed using ...
Jiamin Zhang, Mu Zeng
doaj +1 more source
microRNA. Diagnostic Perspective [PDF]
, 2015 Biomarkers are biological measures of a biological state. An ideal marker should be safe and easy to measure, cost efficient, modifiable with treatment, and consistent across gender and ethnic groups. To date, none of the available biomarkers satisfy all
FARUQ, MD OMAR, VECCHIONE, ANDREA
core +2 more sources
Síndrome carcinoide con afectación cardiaca polivalvular
Cirugía Cardiovascular, 2018 Resumen: La enfermedad cardiaca carcinoide es una causa importante de morbimortalidad para estos pacientes. El pronóstico de esta enfermedad ha mejorado en las últimas décadas, recomendándose un enfoque multidisciplinario en centros de experiencia.
Carlos Domínguez-Massa +3 more
doaj +1 more source
Cases in a series of carcinoid syndrome and carcinoid heart disease [PDF]
Cardiovascular Journal of Africa, 2018 Although carcinoid syndrome is regarded as a rare entity, carcinoid patients with evidence of cardiac involvement show a markedly reduced survival time. Patients with advanced signs of right-sided heart failure represent a subgroup at particularly high risk.
openaire +3 more sources
Hypotension following valve replacement surgery in carcinoid heart disease [PDF]
, 1992 Shahnaz K Hamid, D. N. F. Harris
openalex +1 more source